Stewart Delos Cole, DO Radiology - Diagnostic Radiology Medicare: Medicare Enrolled Practice Location: 4874 Sage Hen Cir, Lake Oswego, OR 97035 Phone: 952-595-1100 Fax: 612-294-4903 |
Michael Jay Goldman, M.D. Radiology - Therapeutic Radiology Medicare: Not Enrolled in Medicare Practice Location: 581 Oak Meadow Dr, Lake Oswego, OR 97034 Phone: 503-516-7142 |
Robert Wesley Seapy, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 17050 Pilkington Rd, Suuite 130, Lake Oswego, OR 97035 Phone: 503-305-5432 Fax: 503-305-7294 |
Amy Suzanne Thurmond, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 17050 Pilkington Rd, 130, Lake Oswego, OR 97035 Phone: 503-305-5432 Fax: 503-305-7294 |
News Archive
John Castellani, the president of the Business Roundtable, told reporters today that health reform legislation should include mechanisms to finance coverage expansions largely through cost savings inside the health care system and should preserve ERISA, the 1974 federal law that regulates most private employee health plans.
New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults. Although those diseases, beta-thalassemia and polycythemia vera, have opposite effects on red blood cell production, treating animals with minihepcidin helps to restore normal levels of red blood cells and reduces spleen enlargement. It also controls the accumulation of excess levels of iron in beta-thalassemia that often causes severe toxic effects.
Using a new gene-editing technique, a team of scientists from UT Southwestern Medical Center stopped progression of Duchenne muscular dystrophy (DMD) in young mice.
While people of Mexican ancestry are nearly twice as likely to develop Type 2 diabetes as people of European heritage, the majority of research in this area has focused on those of European origin.
Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.
› Verified 5 days ago